Careers  |  Sign In  |  Register

Treatment Landscape for Acute Myeloid Leukemia Appears Hopeful for Patients

Eunice Wang, MD, chief of the Leukemia Service at the Roswell Park Comprehensive Cancer Center, discusses the outlook of acute myeloid leukemia (AML) treatment in the wake of new FDA-approved treatment options. Dr. Wang says it is exciting to be involved in the AML therapy field as she believes there are not many other rare cancer types that have seen such an explosion of new agents. Dr. Wang explains these newly approved treatment options help her tailor her treatments to provide personalized patient care for optimal outcomes.

Click here to learn more.